Extended treatment response to imatinib in Rosai-Dorfman disease

Avani Singh, Yael Simons*, John Biren-Fetz, Gayatry Mohapatra, Hongyu Ni, Sujata Gaitonde, Irum Khan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)868-870
Number of pages3
JournalEuropean Journal of Haematology
Volume106
Issue number6
DOIs
StatePublished - Jun 2021

Keywords

  • Rosai-Dorfman disease
  • histiocytosis
  • imatinib

ASJC Scopus subject areas

  • Hematology

Cite this